SEC Form D filing

Monocacy Therapeutics Inc.

Biotech · Seed · Regulation D 506(b) · MD · Filed May 27, 2026

Offering amount: Undisclosed
Exemption: Reg D 506(b)
Issuer state: MD
Filing date: May 27, 2026
Signature date: May 27, 2026
CIK: 0002137361

Public filing directories

Browse directories that group public SEC Form D records by the same filing tags shown on this page. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Sector: Biotech Month: May 2026 Stage and month: Seed

Summary

Auto-generated

Monocacy Therapeutics Inc. in Maryland; biotech company name and no offering amount suggest early-stage.

Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Source

View on SEC EDGAR →Get alerts for filings like this →

FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.